Processa Pharmaceuticals, Inc.
PCSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001533743
In the last 90 days, Processa Pharmaceuticals, Inc. insiders filed 5 open-market purchases and 0 sales; 12 institutions reported holding it in 13F filings for Q2 2026, worth $498.3K in total; no superinvestor holds it.
13F holders, Q2 2023
Institutional positions in Processa Pharmaceuticals, Inc. as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- −3 vs. Q1 2023
- Shares held
- 1.39M
- −260.6K (−15.8%) vs. Q1 2023
- Total value
- $691.4K
- −$161.1K (−18.9%) vs. Q1 2023
- New holders
- 3
- 3 more added
- Sold out
- 6
- 7 more reduced
Compare with Q1 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting PCSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $498.3K |
| Q1 2026 | 10 | $448.5K |
| Q4 2025 | 10 | $331.0K |
| Q3 2025 | 14 | $341.9K |
| Q2 2025 | 13 | $75.9K |
| Q1 2025 | 9 | $63.2K |
| Q4 2024 | 8 | $87.5K |
| Q3 2024 | 8 | $66.5K |
| Q2 2024 | 9 | $101.0K |
| Q1 2024 | 11 | $251.5K |
| Q4 2023 | 18 | $376.5K |
| Q3 2023 | 20 | $349.8K |
| Q2 2023 | 19 | $691.4K |
| Q1 2023 | 22 | $852.6K |
| Q4 2022 | 18 | $1.28M |
| Q3 2022 | 18 | $2.58M |
| Q2 2022 | 18 | $3.24M |
| Q1 2022 | 18 | $3.22M |
| Q4 2021 | 19 | $6.47M |
| Q3 2021 | 18 | $12.2M |
| Q2 2021 | 18 | $11.2M |
| Q1 2021 | 17 | $12.3M |
Institutions, Q2 2023
Shares, value and share of portfolio for each institution holding Processa Pharmaceuticals, Inc.; share changes are against Q1 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Walleye Capital LLC | 366,637 | $182.4K | 0.00% | −367,317−50.0% | Reduced |
| Vanguard Group Inc | 361,679 | $179.9K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 282,837 | $140.7K | 0.00% | +282,837 | New |
| Geode Capital Management, LLC | 68,827 | $34.2K | 0.00% | 00.0% | Unchanged |
| Coastal Bridge Advisors, LLC | 52,500 | $26.1K | 0.01% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 45,400 | $23.0K | 0.00% | +14,200+45.5% | Added |
| State Street Corp | 42,786 | $21.3K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 35,193 | $17.5K | 0.00% | −15,311−30.3% | Reduced |
| Susquehanna International Group, LLP | 28,108 | $14.0K | 0.00% | +28,108 | New |
| Virtu Financial LLC | 26,673 | $13.0K | 0.00% | +13,724+106.0% | Added |
| Verdence Capital Advisors LLC | 20,012 | $9.96K | 0.00% | −5,000−20.0% | Reduced |
| Mirador Capital Partners LP | 18,758 | $9.33K | 0.00% | −1,708−8.3% | Reduced |
| Northern Trust Corp | 15,401 | $7.66K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 10,700 | $5.32K | 0.00% | −51,926−82.9% | Reduced |
| Tower Research Capital LLC (TRC) | 8,796 | $4.38K | 0.00% | −120−1.3% | Reduced |
| Wells Fargo & Company | 3,220 | $1.60K | 0.00% | +65+2.1% | Added |
| Allworth Financial LP | 1,700 | $846 | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 293 | $146 | 0.00% | −29,109−99.0% | Reduced |
| Royal Bank of Canada | 151 | $0 | 0.00% | +151 | New |
| Raymond James Financial Services Advisors, Inc. | 0 | $0 | 0.00% | −48,951−100.0% | Sold out |
| Janney Montgomery Scott LLC | 0 | $0 | 0.00% | −46,231−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −22,459−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −10,040−100.0% | Sold out |
| WealthPLAN Partners, LLC | 0 | $0 | 0.00% | −1,000−100.0% | Sold out |
| Farther Finance Advisors, LLC | 0 | $0 | 0.00% | −487−100.0% | Sold out |